Stemless

The UNIC® Stemless implant can be used in both hemiarthroplasty (HA) and total shoulder arthroplasty (TSA) when combined with anatomical glenoid components (PTEA), in patients eligible for a primary shoulder replacement and exhibiting normal bone mineral density. Osteoporosis and post-traumatic sequelae are contraindications to implantation.

UNIC® Stemless hemiarthroplasty and anatomical total shoulder arthroplasty are indicated for the treatment of symptomatic pain and/or functional impairment of the shoulder in skeletally mature patients, and only in cases where appropriate conservative and analgesic treatments have proven ineffective.

Indications for partial or total anatomical shoulder arthroplasty using the UNIC® Stemless implant include:
– Non-inflammatory degenerative joint disease: centered glenohumeral osteoarthritis, avascular necrosis of the humeral head,
– Inflammatory joint disease: such as rheumatoid arthritis.

Regardless of the underlying condition, the presence of a functional or repairable rotator cuff is an essential prerequisite for considering anatomical partial or total shoulder arthroplasty.